Research & Development: Page 76

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A Look at EDC Implementation

    A Look at EDC Implementation clinicaL-trial Solutions VIEW on E-Solutions October 2007 Keep in mind that any journey begins with a single step. Gregory J. Bailey Director of Programming So you think that EDC is an over publicized topic? What more could possi...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Future of Video in Healthcare Marketing

    The Future of Video in Healthcare Marketing marketing solutions D S Simon Productions Inc. Douglas Simon President and CEO When the FDA approved Viagra in 1998, Pfizer’s video communication strategy featured a video news release. More than 200 million people saw that video, which helped ...

    By PharmaVoice Team • Jan. 2, 2008
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    A new technology frontier By Taren Grom, Editor Letter from the Editor VIEW on E-Solutions October 2007 Social networks, second lives, virtual Websites, online videos, blogs, interactive communications — can it be that we are talking about the latest technologies for the pharmaceutical in...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Interplay Between Adaptive Clinical Trials and E-Clinical Architecture

    Medidata Solutions Worldwide The Interplay Between Adaptive Clinical Trials and E-Clinical Architecture A Coin Toss From Fair to Biased Hugh Levaux VP, Product Strategy About half of all Phase III clinical trials fail to prove the key clinical hypothesis under evaluation; the odds of ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New Healthcare-related Products, Services, and Companies Featured Briefs: The Learning Key Offers Tools for Learning about Partnerships The Learning Key has launched a game, Partnering Success: The Challenge, as a way to make learning fun and memorable. The business-based board game provides trai...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    In his 20 years in the biotechnology industry, Harvey J. Berger, M.D., has witnessed huge leaps in terms of scientific research as well as the development of an industry. Today, as Founder, Chairman, and CEO of Ariad Pharmaceuticals, Dr. Berger has been the driving force in taking the company to ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The 7th Annual PharmaLinx Charity Golf Outing

    We Extend Thanks to These Companies for Their Contributions GOLD CORPORATE SPONSORS Gallagher Benefits Services Inc. J. Knipper and Company Inc. SILVER CORPORATE SPONSORS D. Anderson & Co. InfoMedics Inc. BRONZE CORPORATE SPONSORS CommonHealth Proprint Hole And Prize SponSORs BPG Properties L...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Managed Markets: Military Healthcare

    By Denise Myshko While there has been much focus on the federal government’s role with Medicare drug benefits, there are two other significant healthcare segments for which it is also responsible: veterans and military personnel. In 2005, the Department of Veterans Affairs (VA) spent $4.2 billion...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Adaption Adoption

    By Denise Myshko The double-blind, randomized, parallel group design of clinical trials is so entrenched with well-established processes and systems in the industry that to even consider a change in structure may seem like an uphill battle. But many in the pharmaceutical industry — from pharmaceu...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    An international connection Internet and Physicians in Latin America As in the rest of the world, healthcare professionals from across Latin America use the Internet to be informed, and surprisingly, a majority use their free time to do so. A recent survey by Medimix International shows that most...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    On behalf of the PharmaLinx LLC family, I would like to thank all of those who contributed to the success of the 7th annual charity golf event. Seven years ago, believe it or not, we — Lisa Banket, Marah Walsh, and myself — not only founded the company and began publishing PharmaVOICE but establi...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Managed Markets: Workers' Comp Pharmacy Costs Rising

    By Denise Myshko Total spend for drugs in the workers’ compensation arena is expected to be $5.5 billion in 2007 and represents 15% of total medical costs associated with workers’ compensation. This is the fastest growing component of the system’s medical expense. The use of generic drugs is sign...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Lipitor Perceived as Market Leader Among Statin Brands When it comes to statins, the most frequently discussed issue in the blogosphere and general online world is the negative side effects. This is one of the findings in a recent report fielded ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Online update SURF’s UP According to Manhattan Research’s latest study, physician site traffic is spread among product sites of new and early-launch stage treatments, those with clinical news coverage, and, consistent with years past, products with a significant consumer advertising component. “W...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Table of Contents September 2007 On the Cover Success Beyond the Silos Innovative pharmaceutical companies are redefining the communications process by tearing down the walls between the different factions: agencies, sales, marketing, and public relations. FEATURES Postmarketing Safety in the Spo...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HIV Market: Stability in Motion

    By Denise Myshko In response to several challenges, the focus of biotech and pharmaceutical development in HIV has shifted to novel classes. HIV is a retrovirus that is constantly adapting and evolving. Rates of drug-related resistance are on the rise and not all antiretroviral agents work for al...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    Industry Events September 2007 On the Calendar September 16-18 3rd Annual Growth Innovation and Leadership 2007 Hyatt Regency Monterey, Monterey, Calif. For more information, contact Melina Trevino, Frost & Sullivan, at 210-247-2440, e-mail [email protected], or visit frost.com. Septem...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    PharmaLinx Launches Industry Web Portal Professionals who operate in the pharmaceutical, biotechnology, and medical-device sectors, as well as those who provide services and tools to the industry, now have a single source to find targeted information related to their fields. The new portal, Acces...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    DIA 2007 -- Annual Conference

    DIA Addresses extreme topics The 43rd Annual Meeting of the Drug Information Association DIA 2007 — Annual Conference The Drug Information Association’s 43rd annual meeting featured 450 sessions and more than 1,000 speakers. Industry Thought Leaders Raise their VOICE at DIA Podcasts BBK Worldwide...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    7 Rules for New War Games

    Stan Bernard of Bernard Associates says practicing competitive simulations is a better approach than war games because simulations address more of the challenges that companies face. Traditionally, businesses have engaged in war games, in which marketing groups or brand teams compete by dividing ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A Born Leader -- Ethan Leder

    By Kim Ribbink Ethan Leder has made a career out of establishing companies in niche markets. Now he is applying the skills he’s learned to evidence-based solutions specialist United BioSource Corp. With an entrepreneurial spirit and intense work ethic, Ethan D. Leder has made a career out of esta...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    The pharmaceutical industry can no longer afford to be off-message — not even just once — in an exceedingly competitive marketplace. Silo busting continues to be a resounding theme in all areas of the industry, it’s a way to improve business processes, increase efficiencies, and stay on message. ...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Throughout his career, Joseph Bolen, Ph.D., has been involved in unraveling the mysteries of drug discovery. Now in his positions as Senior VP of Research and Drug Discovery, a role in which he heads all biological research and related functions as well as all drug-discovery functions, and as Chi...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Strengthening the Value of Live CME: Cutting-Edge Strategies to Engage Learners and Extend Reach

    VIEW on Medical Education August 2007 Strengthening the Value of Live CME: Cutting-Edge Strategies to Engage Learners and Extend Reach Sarah Mooney, Director, Strategic Planning & Development Innovia Education Institute LLC In 2006, more than 2 million physicians and healthcare pr...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Transforming U.S. Healthcare Quality Using CME

    Transforming U.S. Healthcare Quality Using CME VIEW on Medical Education August 2007 cme2 Cathy Pagano, Executive Director John Marlow, Chief Medical Officer We believe the mission of all CME needs to be elevated to a whole new level to be clinically meaningful. Looking ahead, a new model...

    By PharmaVoice Team • Jan. 2, 2008